Procore Technologies shares are lower in Friday trading, pressured by renewed attention on insider selling after reports highlighting a large March 10, 2026 sale by director Craig F. Courtemanche Jr. The selling headline is hitting a stock that has already been trending down year-to-date, making the tape sensitive to any perceived negative signal around leadership conviction and valuation. †cite†turn3search1†cite†turn1search5†cite†turn0search1†cite†turn3search4†cite†turn3search5â€

The latest selling focus centers on a March 10, 2026 insider transaction totaling roughly $3.2 million, which has become a near-term overhang as investors debate whether the move was primarily liquidity/portfolio management or a caution signal. Separately, Procore disclosed executive changes with a CFO designate and a CRO designate joining March 10, 2026, with both set to assume full roles on April 1, 2026—a transition period that can add uncertainty for momentum-driven software names. †cite†turn3search1†cite†turn2search9†cite†turn0search7†cite†turn1search3â€

Procore’s most recent earnings update (released February 12, 2026) showed Q4 revenue growth and included guidance for Q1 and full-year 2026, but the stock’s narrative remains caught between steady top-line expansion and the company’s path to consistent profitability. Some third-party post-earnings commentary emphasized that the company’s 2026 outlook implies slower growth than prior periods, which can amplify downside reactions when incremental negative catalysts (like insider-selling headlines) emerge. †cite†turn0search1†cite†turn3search4†cite†turn3search5â€

Next catalysts include upcoming quarterly results and any additional disclosures around leadership transitions as the April 1, 2026 CFO/CRO handoffs become effective. Traders will also watch whether additional insider transactions appear, and whether sell-side target changes or thesis shifts follow the recent insider-selling attention. †cite†turn0search9†cite†turn0search7†cite†turn3search1â€